BioSpace News Archive

PTSD is the root cause of suicide and is “one of the deadliest wounds of war.” Within an hour of you reading this, a veteran will have taken his life.

Africa Clinical Research Management, Ltd (ACE Research), have entered into a strategic partnership to more comprehensively serve the global health drug development research efforts of academic, non-profit, and industry clients.

Kite, a Gilead Company, and Humanigen, Inc. (HGEN) announced today the formation of a clinical collaboration to conduct a Phase 1/2 study of lenzilumab, an investigational anti-GM-CSF monoclonal antibody, with Yescarta® in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), today filed its Notice of Meeting and Management Information Circular. Aurinia plans to host its upcoming Annual General Meeting of Shareholders (“AGM”) at 10:00 a.m. MT on Wednesday, June 26, 2019, at the Westin Calgary, 320 4th Ave SW in Calgary, Alberta.

The Northwell Health Board of Trustees on Wednesday elected Michael A. Epstein of Sands Point, Long Island, as its new chair.

WAT Medical, a company that develops safe, effective, and user-friendly wearable medical products, recently announced that HeadaTerm, its migraine treatment product, has received official clearance from TGA Australia.

Oncology researchers and clinicians seeking to deepen their understanding of Microsatellite Instability (MSI) have a new resource that gathers a wealth of information in one place, including the importance of MSI as a biomarker and methods of detection.

Hospital corporations across Massachusetts have placed at least $1.6 billion in the Cayman Islands and other well-known offshore tax havens, leading nurses and lawmakers to call for legislation requiring financial transparency from hospitals and the returning of excess profits and CEO pay to the public good.

The Ontario Bioscience Innovation Organization (OBIO®) announced the launch of its latest publication, “OBIO Talent Toolkit: Health to Business Bridge Program Guide.”

Valent BioSciences (VBC) announced that Randy Martin Ph.D. has been named Global Technical Development Specialist for the company’s burgeoning soil health business. Martin, who had previously managed VBC’s R&D pipeline, brings more than 30 years of experience in the agricultural biologicals space.